MMCM
LH icon

Murphy & Mullick Capital Management’s Labcorp LH Stock Holding History

Murphy & Mullick Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96K Hold
7
– – ﹤0.01% 615
2026
Q1 		$1.87K Buy
+7
New +$1.9K ﹤0.01% 607

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Murphy & Mullick Capital Management's LH Position: Q2 2026 in Review

Murphy & Mullick Capital Management held its Labcorp (LH) position steady in Q2 2026 at 7 shares worth $1.96K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Murphy & Mullick Capital Management first reported a position in LH in Q1 2026 and has held it in 2 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Murphy & Mullick Capital Management held 7 shares of Labcorp worth $1.96K as of Q2 2026.
  • Murphy & Mullick Capital Management left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #615 holding.
  • Murphy & Mullick Capital Management first reported a position in Labcorp in Q1 2026 and has held it in 2 quarters since.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.